PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 175 filers reported holding PRECIGEN INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71 | +22.4% | 50,000 | 0.0% | 0.01% | +33.3% |
| Q2 2023 | $58 | +9.4% | 50,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $53 | -30.3% | 50,000 | 0.0% | 0.01% | -25.0% |
| Q4 2022 | $76 | -99.9% | 50,000 | 0.0% | 0.01% | -27.3% |
| Q3 2022 | $106,000 | +58.2% | 50,000 | 0.0% | 0.01% | +22.2% |
| Q2 2022 | $67,000 | -36.8% | 50,000 | 0.0% | 0.01% | -18.2% |
| Q1 2022 | $106,000 | -43.0% | 50,000 | 0.0% | 0.01% | -26.7% |
| Q4 2021 | $186,000 | -25.6% | 50,000 | -0.0% | 0.02% | -28.6% |
| Q3 2021 | $250,000 | -23.3% | 50,001 | 0.0% | 0.02% | -25.0% |
| Q2 2021 | $326,000 | -5.5% | 50,001 | 0.0% | 0.03% | 0.0% |
| Q1 2021 | $345,000 | -32.4% | 50,001 | 0.0% | 0.03% | -36.4% |
| Q4 2020 | $510,000 | +191.4% | 50,001 | 0.0% | 0.04% | +41.9% |
| Q3 2020 | $175,000 | -30.0% | 50,001 | 0.0% | 0.03% | -35.4% |
| Q2 2020 | $250,000 | +47.1% | 50,001 | 0.0% | 0.05% | +33.3% |
| Q1 2020 | $170,000 | – | 50,001 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 11,243,560 | $12,930,093 | 0.72% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 3,333,468 | $3,833,488 | 0.36% |
| First Washington CORP | 592,975 | $681,921 | 0.30% |
| Fore Capital, LLC | 490,000 | $563,500 | 0.26% |
| EMFO, LLC | 180,000 | $207,000 | 0.19% |
| MSD Partners, L.P. | 960,000 | $1,104,000 | 0.10% |
| SANDERS MORRIS HARRIS LLC | 325,000 | $373,750 | 0.08% |
| Virtus ETF Advisers LLC | 87,692 | $100,846 | 0.06% |
| XTX Topco Ltd | 263,046 | $302,503 | 0.05% |
| CHIRON CAPITAL MANAGEMENT, LLC | 45,906 | $52,792 | 0.04% |